citalopram and fluvoxamine

citalopram has been researched along with fluvoxamine in 139 studies

Research

Studies (139)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (7.19)	18.7374
1990's	32 (23.02)	18.2507
2000's	40 (28.78)	29.6817
2010's	44 (31.65)	24.3611
2020's	13 (9.35)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Qin, W; Tian, S; Wold, EA; Xu, Q; Ye, N; Zhen, XC; Zhou, J	1
Bojarski, AJ; Bugno, R; Duszyńska, B; Hogendorf, A; Hogendorf, AS; Kurczab, R; Lenda, T; Pietruś, W; Satała, G; Staroń, J; Wantuch, A; Warszycki, D	1
Karsch, V; Starke, K; Szabo, B	1
Crewe, HK; Haddock, RE; Lennard, MS; Tucker, GT; Woods, FR	1
Fuller, RW	1
Asberg, M; Eriksson, B; Mårtensson, B; Träskman-Bendz, L; Wägner, A	1
Mendels, J	1
Melzacka, M; Pawłowski, L	1
Durcan, MJ; Eckardt, MJ; Linnoila, M; Lister, RG	2
Maj, J; Rogóz, Z; Skuza, G	1
Agarwal, SK; Dhawan, BN; Gulati, A; Shukla, R; Srimal, RC	1
Constantinidis, J; Dick, P; Tissot, R	1
Maj, J; Rogóz, Z; Skuza, G; Sowińska, H	1
Baumann, P; Rochat, B	1
Hyttel, J; Sánchez, C	1
Brøsen, K	2
Baumann, P; Eap, CB; Hemmeter, U; Holsboer-Trachsler, E; Seifritz, E	1
Hashimoto, S; Inoue, T; Koyama, T	1
Artigas, F; Bel, N	1
Brøsen, K; Gram, LF; Jeppesen, U; Loft, S; Poulsen, HE; Vistisen, K	1
Catalano, M; Lucca, A; Lucini, V; Smeraldi, E	1
Harnett-Sheehan, K; Sheehan, DV	1
Haffmans, PM; Hoogduin, CA; Timmerman, L	1
Baumann, P; Eap, CB	1
Baumann, P; Bertschy, G; Bondolfi, G; Chautems, C; Rochat, B	1
Meier, E; Sánchez, C	1
Earley, B; Faherty, CJ; Leonard, BE	1
Bourin, M; Redrobe, JP	2
Bellodi, L; Bianchi, L; Mundo, E	1
Belpaire, FM; Brøsen, K; Rasmussen, BB; Temmerman, A; Wijnant, P	1
Barbey, JT; Roose, SP	1
Gram, LF	1
Stahl, SM	1
Daws, LC; Frazer, A	1
Anand, VS; Dewan, MJ	1
Bajo, S; Battaglia, M; Bellodi, L; Pegna, C	1
Meyers, BS	1
De Vry, J; Maurel, S; Schreiber, R	1
Carleborg, L; Hägg, S; Ohman, R; Spigset, O	1
Bakker, A	1
Linnet, K; Olesen, OV	1
Härtter, S; Hiemke, C	1
Bertilsson, L; Röjdmark, S; Tybring, G; Ursing, C; von Bahr, C; Yasui, N	1
Buzinkaiová, T; Polonský, J	1
Bergsholm, YK; Bøhler, E; Nordeng, H; Spigset, O	1
Knoke, DM; Naranjo, CA	1
Bellodi, L; Cavallini, MC; Cavedini, P; Diaferia, G; Erzegovesi, S; Locatelli, M	1
Cullen, N; Lexell, J; Zafonte, RD	1
Droogmans, G; Maertens, C; Nilius, B; Verbesselt, R	1
Anderson, TA; Dobscha, SK; Hauser, P; Hoffman, WF; Snodgrass, LS; Turner, EH; Winterbottom, LM	1
Brocco, M; Girardon, S; Millan, MJ; Veiga, S	1
Broocks, A; Hohagen, F; Kordon, A	1
Almarza, E; Martínez, MA; Sánchez de la Torre, C	1
Eichner, SF; Jones, JR; Moore, ML	1
Armbrust, KL; Black, MC; Henry, TB; Kwon, JW	1
Albert, U; Bogetto, F; Maina, G; Salvi, V	1
Sharma, S; Tandon, R; Trivedi, JK	1
Gooch, S; Solomons, K; Wong, A	1
Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C	1
Fava, M; Mallinckrodt, CH; Martinez, JM; Prakash, A; Watkin, JG; Wohlreich, MM	1
Carrasco, JL; Sandner, C	1
Arias, B; Catalán, R; Fañanás, L; Gastó, C; Lorenzi, C; Serretti, A	1
Goldman, S	1
Pick, CG; Schreiber, S	1
Abraham, G; Milev, R; Stuart Lawson, J	1
Cherng, CF; Hsiao, SY; Yang, YK; Yeh, TL; Yu, L	1
Berger, U; Jensen, E; Kallenborn, R; Samuelsen, PJ; Vasskog, T	1
Bailly, D	1
Görker, I; Hergüner, S; Kilinçaslan, A; Tüzün, U	1
Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME	1
Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A	1
Lejoyeux, M	1
Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R	1
Apparsundaram, S; Henningsen, RA; Jia, Z; Kondru, RK; Leung, B; Martin, RS; Milla, ME; Suen, A	1
Ikonomidis, I; Kremastinos, DT; Lekakis, J; Moutsatsou, P; Nikolaou, M; Papoutsi, Z; Parissis, J	1
Coelho, EB; Lanchote, VL; Rocha, A	1
Imai, T; Inoue, K; Nagata, K; Tozaki-Saitoh, H; Tsuda, M; Yamashita, T	1
Debonnel, G; Du, J; Haddjeri, N; Lucas, G; Mnie-Filali, O; Piñeyro, G; Romeas, T	1
Charles, D; Fava, M; Papakostas, GI	1
Dormuth, CR; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS	1
Dormuth, C; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS	1
Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P	1
Mochcovitch, MD; Nardi, AE	1
Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M	1
Hazell, P; Silove, N; Wheeler, DM; Williams, K	1
Deshpande, A; Ing, A; Rizo, C; Seeman, N	1
Dobzhenko, MN; Shchepotin, IB; Zotov, AS	1
Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G	1
Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA	1
Gotzlav, Y; Iancu, I; Kertzman, S; Kotler, M; Reznik, I; Vainder, M; Weizman, A	1
Gorman, DA; Lam, D; Patten, S; Pringsheim, T	1
Brignell, A; Hazell, P; Randall, M; Silove, N; Williams, K	1
Barak, Y; Baratz-Goldstein, R; Hostovsky, A; Pick, CG; Rubovitch, V; Schreiber, S; Volis, I	1
Hermann, M; Molden, E; Waade, RB	1
Al-Aieshy, F; Alcalai, R; Hirsh-Rokach, B; Lotan, A; Malmström, RE; Ritter, A; Shai, E; Spectre, G; Varon, D	1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N	1
Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D	1
Halling-Sørensen, B; Hansen, CH; Jacobsen, NW; Nellemann, C; Styrishave, B	1
Egashira, N; Kuwahara, J; Masuda, S; Ueda, M; Ushio, S; Yamada, T; Zukeyama, N	1
Bloch, MH; Freemantle, N; Jakubovski, E; Taylor, MJ; Varigonda, AL	1
Creedon, TB; Hodgkin, D; Horgan, CM; Merrick, EL; Stewart, MT	1
Inoue, Y; Ishioka, M; Kubo, K; Nakamura, K; Tsuchimine, S; Yasui-Furukori, N	1
Li, Y; Lu, X; Tao, C; Yan, W	1
Asghari, A; Bazregar, M; Fahimi, E; Fahimirad, B; Rajabi, M	1
Casavant, MJ; Chounthirath, T; Russell, JL; Spiller, HA	1
Brekke, M; Molden, E; Skogvoll, E; Spigset, O; Westin, AA	1
Carleton, BC; Etminan, M; Guo, M; Procyshyn, RM; Sodhi, M	1
Araujo, M; Benevent, J; Bondon-Guitton, E; Chebane, L; Durrieu, G; Montastruc, F; Montastruc, JL; Ojero-Senard, A	1
Finkelstein, Y; Gomes, T; Juurlink, DN; Li, P; Macdonald, EM; Mamdani, MM	1
Funahashi, H; Haruta-Tsukamoto, A; Ishida, Y; Miyahara, Y; Naono-Nakayama, R; Nishimori, T	1
Assimon, MM; Brookhart, MA; Flythe, JE	1
Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA	1
Liao, XM; Si, TM; Su, YA; Wang, Y; Yu, X	1
Hui, A	1
Chen, L; Feng, X; Huang, C; Shen, X; Wang, J; Xu, T	1
Kalisch Ellett, LM; Kassie, GM; Nguyen, TA; Pratt, NL; Roughead, EE	1
Aghaeepour, N; Maric, I; Oskotsky, B; Oskotsky, T; Sirota, M; Stevenson, DK; Tang, A; Wong, RJ	1
Komarov, SD; Severtsev, VV; Vdovin, AS; Vinnikova, MA	1
Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Gaynes, BN; Pun, PH; Winkelmayer, WC	1
Gecaite-Stonciene, J; Hoffman, J; Lochner, C; Stein, DJ; Williams, T	1
Azoulay, L; Cao, TXD; Fergusson, E; Filliter, C; Montastruc, F; Rej, S; Renoux, C; Yu, OHY	1
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K	1
Liu, M; Maxwell-Horn, AC; Rossow, KM; Saucier, LA; Van Driest, SL	1

Reviews

39 review(s) available for citalopram and fluvoxamine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24 Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries	2020
Biochemical pharmacology of the serotonin system. Advances in neurology, 1986, Volume: 43 Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine	1986
Therapeutic effects of serotonin uptake inhibitors in depression. The Journal of clinical psychiatry, 1986, Volume: 47 Suppl Topics: 5-Hydroxytryptophan; Alanine; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Propylamines; Serotonin; Serotonin Antagonists; Trazodone; Zimeldine	1986
Clinical experience with serotonin reuptake inhibiting antidepressants. The Journal of clinical psychiatry, 1987, Volume: 48 Suppl Topics: Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Oximes; Propylamines; Serotonin Antagonists; Zimeldine	1987
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. International clinical psychopharmacology, 1995, Volume: 10 Suppl 1 Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism	1995
The pharmacogenetics of the selective serotonin reuptake inhibitors. The Clinical investigator, 1993, Volume: 71, Issue:12 Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors	1993
Are pharmacokinetic drug interactions with the SSRIs an issue? International clinical psychopharmacology, 1996, Volume: 11 Suppl 1 Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Liver; Selective Serotonin Reuptake Inhibitors	1996
The role of SSRIs in panic disorder. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 10 Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1996
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients. Journal of chromatography. B, Biomedical applications, 1996, Nov-08, Volume: 686, Issue:1 Topics: 1-Naphthylamine; Chromatography; Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1996
SSRI safety in overdose. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 15 Topics: Adult; Child; Citalopram; Drug Overdose; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Poison Control Centers; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	1998
Serotonin transporter function in vivo: assessment by chronoamperometry. Annals of the New York Academy of Sciences, 1998, Dec-15, Volume: 861 Topics: Animals; Citalopram; Dentate Gyrus; Electrochemistry; Fluvoxamine; Hippocampus; Rats; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Signal Transduction	1998
Depression and dementia: comorbidities, identification, and treatment. Journal of geriatric psychiatry and neurology, 1998,Winter, Volume: 11, Issue:4 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline	1998
Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacology & therapeutics, 2000, Volume: 85, Issue:1 Topics: Citalopram; Clinical Trials as Topic; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2000
The role of selective serotonin reuptake inhibitors in reducing alcohol consumption. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 20 Topics: Alcohol Drinking; Alcoholism; Animals; Behavior, Addictive; Behavior, Animal; Citalopram; Clinical Trials as Topic; Comorbidity; Drinking Behavior; Drug Evaluation, Preclinical; Fluoxetine; Fluvoxamine; Humans; Mice; Rats; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2001
Serotonin agents in the treatment of acquired brain injury. The Journal of head trauma rehabilitation, 2002, Volume: 17, Issue:4 Topics: Brain Injuries; Citalopram; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Injury Severity Score; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2002
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania	2003
Treating functional impairment of autism with selective serotonin-reuptake inhibitors. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:9 Topics: Autistic Disorder; Citalopram; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview. International journal of clinical practice, 2005, Volume: 59, Issue:12 Topics: Antidepressive Agents, Second-Generation; Citalopram; Fluoxetine; Fluvoxamine; Humans; Mood Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2005
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:10 Pt 2 Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted	2006
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biological psychiatry, 2008, Feb-15, Volume: 63, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2008
[Compulsive buying: psychological and biological treatment]. L'Encephale, 2007, Volume: 33, Issue:Pt 3 Topics: Adult; Antidepressive Agents; Bipolar Disorder; Citalopram; Commerce; Compulsive Behavior; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Middle Aged; Panic Disorder	2007
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstetrics and gynecology, 2008, Volume: 111, Issue:5 Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2008
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:2 Pt 2 Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2010
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. International clinical psychopharmacology, 2010, Volume: 25, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult	2010
Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies. Expert review of neurotherapeutics, 2010, Volume: 10, Issue:8 Topics: Citalopram; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Placebo Effect; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2010
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update. Postgraduate medicine, 2010, Volume: 122, Issue:4 Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens	2010
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). The Cochrane database of systematic reviews, 2010, Aug-04, Issue:8 Topics: Adult; Age Factors; Autistic Disorder; Child; Citalopram; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2010
[Selective serotonin reuptake inhibitors and mammary pathologies]. Voprosy onkologii, 2010, Volume: 56, Issue:4 Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline	2010
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions. Current medicinal chemistry, 2012, Volume: 19, Issue:12 Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride	2012
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). The Cochrane database of systematic reviews, 2013, Aug-20, Issue:8 Topics: Adult; Age Factors; Autistic Disorder; Child; Child Development Disorders, Pervasive; Citalopram; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2013
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults. The Cochrane database of systematic reviews, 2015, 05-01, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride	2015
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder. The American journal of psychiatry, 2016, Feb-01, Volume: 173, Issue:2 Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2016
Antidepressant pharmacogenetics in children and young adults: A systematic review. Journal of affective disorders, 2019, 07-01, Volume: 254 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult	2019
Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain. PloS one, 2020, Volume: 15, Issue:12 Topics: Algorithms; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Desvenlafaxine Succinate; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Psychometrics; Sertraline; Treatment Outcome	2020
Recent sample pretreatment methods for determination of selective serotonin reuptake inhibitors (SSRIs) in biological samples. Journal of pharmaceutical and biomedical analysis, 2021, Nov-30, Volume: 206 Topics: Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2021
Efficacy and tolerability of pharmacotherapy for obsessive-compulsive personality disorder: a systematic review of randomized controlled trials. Expert opinion on pharmacotherapy, 2022, Volume: 23, Issue:11 Topics: Citalopram; Compulsive Personality Disorder; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic	2022
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Molecular psychiatry, 2023, Volume: 28, Issue:1 Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine	2023
Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision support. Pharmacotherapy, 2023, Volume: 43, Issue:7 Topics: Adult; Child; Citalopram; Decision Support Systems, Clinical; Fluvoxamine; Humans; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors	2023

Trials

12 trial(s) available for citalopram and fluvoxamine

Article	Year
Clinical experience with serotonin reuptake inhibiting antidepressants. The Journal of clinical psychiatry, 1987, Volume: 48 Suppl Topics: Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Oximes; Propylamines; Serotonin Antagonists; Zimeldine	1987
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine. European journal of clinical pharmacology, 1996, Volume: 51, Issue:1 Topics: Adult; Aryl Hydrocarbon Hydroxylases; Caffeine; Chromatography, High Pressure Liquid; Citalopram; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sparteine	1996
Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group. International clinical psychopharmacology, 1996, Volume: 11, Issue:3 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Diarrhea; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Middle Aged; Nausea; Outpatients; Paresthesia; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	1996
Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation. Psychopharmacology, 1996, Volume: 128, Issue:4 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Tremor	1996
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Single-Blind Method	1997
Citalopram and fluvoxamine in Tourette's disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:3 Topics: Adolescent; Child; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluvoxamine; Humans; Male; Neurologic Examination; Selective Serotonin Reuptake Inhibitors; Tourette Syndrome	1999
Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. European journal of clinical pharmacology, 2000, Volume: 56, Issue:2 Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Citalopram; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Double-Blind Method; Female; Fluvoxamine; Humans; Hydroxylation; Male; Melatonin; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors	2000
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10 Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain	2004
T3 augmentation of SSRI resistant depression. Journal of affective disorders, 2006, Volume: 91, Issue:2-3 Topics: Adult; Aged; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Resistance; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Triiodothyronine	2006
Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules. International journal of cardiology, 2010, Mar-04, Volume: 139, Issue:2 Topics: Adult; Aged; Aorta; Cell Adhesion; Cell Survival; Chronic Disease; Citalopram; Depression; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Fluvoxamine; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Monocytes; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Cell Adhesion Molecule-1	2010
Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial. Pharmacotherapy, 2015, Volume: 35, Issue:2 Topics: Adult; Citalopram; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Double-Blind Method; Drug Interactions; Fluvoxamine; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prodrugs; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Young Adult	2015
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Volume: 121, Issue:12 Topics: Alcoholism; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2021

Other Studies

89 other study(ies) available for citalopram and fluvoxamine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Inhibition of P-glycoprotein by newer antidepressants. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1 Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection	2003
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Species independence in brain tissue binding using brain homogenates. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity	2011
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine. European journal of medicinal chemistry, 2021, Aug-05, Volume: 220 Topics: Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Ligands; Models, Molecular; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship	2021
Effects of inhibitors of neuronal uptake of 5-HT on sympathetic cardiovascular regulation. Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:1 Topics: Analysis of Variance; Animals; Blood Platelets; Blood Pressure; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Heart Rate; Norepinephrine; Rabbits; Serotonin; Sympathetic Nervous System	1992
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. British journal of clinical pharmacology, 1992, Volume: 34, Issue:3 Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sparteine	1992
Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram. Psychopharmacology, 1986, Volume: 88, Issue:3 Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Brain; Chromatography, Gas; Citalopram; Fluvoxamine; Male; Oximes; Propylamines; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Time Factors	1986
Interactions of 5HT reuptake inhibitors and ethanol in tests of exploration and anxiety. Advances in alcohol & substance abuse, 1988, Volume: 7, Issue:3-4 Topics: Animals; Anxiety; Citalopram; Desipramine; Drug Interactions; Ethanol; Exploratory Behavior; Fluoxetine; Fluvoxamine; Mice; Mice, Inbred Strains; Motor Activity; Oximes; Serotonin Antagonists	1988
Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration. Psychopharmacology, 1988, Volume: 96, Issue:4 Topics: Animals; Anxiety; Citalopram; Desipramine; Ethanol; Exploratory Behavior; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Oximes; Serotonin Antagonists	1988
5-Hydroxytryptamine uptake inhibitors antagonize the antireserpine effects of noradrenaline uptake inhibitors. The Journal of pharmacy and pharmacology, 1983, Volume: 35, Issue:2 Topics: Animals; Brompheniramine; Citalopram; Fluvoxamine; Male; Mice; Motor Activity; Norepinephrine; Oximes; Propylamines; Reserpine; Serotonin Antagonists; Tetrabenazine; Zimeldine	1983
Evidence for the lack of serotonergic mechanism in the regulation of blood-brain barrier. Pharmacological research communications, 1984, Volume: 16, Issue:2 Topics: Animals; Blood-Brain Barrier; Cats; Citalopram; Dogs; Evans Blue; Female; Fluorescein; Fluoresceins; Fluvoxamine; Male; Methysergide; Oximes; Propylamines; Serotonin	1984
Antidepressants and serotonin neurons of the raphe. Neuropsychobiology, 1981, Volume: 7, Issue:3 Topics: Animals; Antidepressive Agents, Tricyclic; Benzofurans; Brain Stem; Citalopram; Clomipramine; Ethers; Fluvoxamine; Imipramine; Indoles; Locus Coeruleus; Male; Microscopy, Fluorescence; Norepinephrine; Oximes; Piperidines; Propylamines; Raphe Nuclei; Rats; Receptors, Serotonin; Serotonin	1981
Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice. Journal of neural transmission, 1982, Volume: 55, Issue:1 Topics: Aggression; Animals; Antidepressive Agents; Citalopram; Clonidine; Drug Interactions; Fluoxetine; Flupenthixol; Fluvoxamine; Humans; Male; Mice; Oximes; Pizotyline; Propylamines; Stereoisomerism	1982
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. European journal of pharmacology, 1994, Nov-03, Volume: 264, Issue:3 Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes	1994
Increased trimipramine plasma levels during fluvoxamine comedication. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1994, Volume: 4, Issue:1 Topics: Aged; Citalopram; Depressive Disorder; Dextromethorphan; Drug Interactions; Female; Fluvoxamine; Humans; Mephenytoin; Phenotype; Trimipramine	1994
Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology, 1996, Volume: 123, Issue:2 Topics: Animals; Behavior, Animal; Citalopram; Dose-Response Relationship, Drug; Fear; Fluvoxamine; Male; Maprotiline; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors	1996
In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:3 Topics: Adrenergic Uptake Inhibitors; Animals; Carrier Proteins; Cerebral Cortex; Citalopram; Clonidine; Desipramine; Fluoxetine; Fluvoxamine; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters	1996
Predicting value of tryptophan/large neutral amino acids ratio on selective serotonin reuptake inhibitors. Advances in experimental medicine and biology, 1996, Volume: 398 Topics: Amino Acids; Antidepressive Agents; Biomarkers; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Tryptophan	1996
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology, 1997, Volume: 129, Issue:3 Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal	1997
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat. Journal of psychopharmacology (Oxford, England), 1997, Volume: 11, Issue:1 Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test. European journal of pharmacology, 1997, May-01, Volume: 325, Issue:2-3 Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Desipramine; Drug Interactions; Fluoxetine; Fluvoxamine; Imipramine; Ketanserin; Male; Maprotiline; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming	1997
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors. European journal of clinical pharmacology, 1998, Volume: 54, Issue:3 Topics: 1-Naphthylamine; Adult; Anti-Arrhythmia Agents; Child; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Kinetics; Male; Methylation; Metoprolol; Microsomes, Liver; Oxidation-Reduction; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors; Sertraline	1998
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. Psychopharmacology, 1998, Volume: 138, Issue:2 Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming	1998
[Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)]. Ugeskrift for laeger, 1998, Dec-07, Volume: 160, Issue:50 Topics: Adult; Antidepressive Agents; Citalopram; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1998
Using secondary binding properties to select a not so selective serotonin reuptake inhibitor. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:12 Topics: Adolescent; Adult; Child; Citalopram; Cytochrome P-450 Enzyme System; Drug Prescriptions; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1998
Evaluating the tolerability of the newer antidepressants. The Journal of nervous and mental disease, 1999, Volume: 187, Issue:2 Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride	1999
Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats. Alcohol (Fayetteville, N.Y.), 1999, Volume: 17, Issue:3 Topics: Alcohol Drinking; Alcoholism; Animals; Citalopram; Disease Models, Animal; Eating; Ethanol; Female; Fluoxetine; Fluvoxamine; Food Preferences; Male; Paroxetine; Rats; Rats, Mutant Strains; Selective Serotonin Reuptake Inhibitors	1999
Excretion of paroxetine into breast milk. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:8 Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides	1999
[Severe withdrawal symptoms with fever upon stopping paroxetine]. Nederlands tijdschrift voor geneeskunde, 1999, Aug-28, Volume: 143, Issue:35 Topics: Citalopram; Drug Administration Schedule; Fever; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	1999
Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes. Pharmacology, 1999, Volume: 59, Issue:6 Topics: Citalopram; Cytochrome P-450 Enzyme System; DNA, Complementary; Fluvoxamine; Gene Expression; Humans; Ketoconazole; Kinetics; Methylation; Microsomes, Liver; Oxidation-Reduction; Quinidine; Recombinant Proteins; Stereoisomerism	1999
Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis. Electrophoresis, 2000, Volume: 21, Issue:14 Topics: Citalopram; Electrophoresis, Capillary; Fluoxetine; Fluvoxamine; Selective Serotonin Reuptake Inhibitors; Sertraline	2000
[The transfer of selective serotonin reuptake inhibitors to human milk]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2001, Jan-20, Volume: 121, Issue:2 Topics: Antidepressive Agents; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Milk, Human; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2001
Clinical predictors of drug response in obsessive-compulsive disorder. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:5 Topics: Adolescent; Adult; Aged; Analysis of Variance; Citalopram; Clomipramine; Drug Resistance; Female; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Psychological Tests; Random Allocation; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2001
Block of volume-regulated anion channels by selective serotonin reuptake inhibitors. Naunyn-Schmiedeberg's archives of pharmacology, 2002, Volume: 366, Issue:2 Topics: Antidepressive Agents; Cells, Cultured; Chloride Channels; Citalopram; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluvoxamine; Humans; Hydrogen-Ion Concentration; Hypotonic Solutions; Inhibitory Concentration 50; Membrane Potentials; Paroxetine; Patch-Clamp Techniques; Pulmonary Artery; Selective Serotonin Reuptake Inhibitors; Sertraline	2002
Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center. Psychiatric services (Washington, D.C.), 2003, Volume: 54, Issue:2 Topics: Citalopram; Clinical Pharmacy Information Systems; Cost Control; Cost Savings; Drug Administration Schedule; Drug Costs; Drug Utilization; Fluoxetine; Fluvoxamine; Hospital Costs; Hospitals, Veterans; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	2003
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes. Psychopharmacology, 2003, Volume: 168, Issue:4 Topics: Animals; Citalopram; Environment Design; Fluvoxamine; Injections, Subcutaneous; Male; Mice; Motor Activity; Movement Disorders; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists	2003
A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection. Journal of analytical toxicology, 2004, Volume: 28, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chromatography, Gas; Chromatography, Liquid; Citalopram; Doxepin; Female; Fluvoxamine; Humans; Mianserin; Nitrogen; Paroxetine; Phosphorus; Reproducibility of Results; Trazodone	2004
Neonatal complications after intrauterine exposure to SSRI antidepressants. Prescrire international, 2004, Volume: 13, Issue:71 Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environmental toxicology and chemistry, 2004, Volume: 23, Issue:9 Topics: Animals; Citalopram; Cladocera; Ecosystem; Female; Fluoxetine; Fluvoxamine; Lethal Dose 50; Male; No-Observed-Adverse-Effect Level; Paroxetine; Reproduction; Selective Serotonin Reuptake Inhibitors; Sertraline; Toxicity Tests, Acute; Toxicity Tests, Chronic; Water Pollutants, Chemical	2004
Depression in general clinical practice. Journal of the Indian Medical Association, 2004, Volume: 102, Issue:10 Topics: Age Factors; Aged; Antidepressive Agents; Citalopram; Depression; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Risk Factors; Treatment Outcome	2004
Toxicity with selective serotonin reuptake inhibitors. The American journal of psychiatry, 2005, Volume: 162, Issue:6 Topics: Adult; Chemical and Drug Induced Liver Injury; Citalopram; Depressive Disorder; Female; Fluvoxamine; Hepatorenal Syndrome; Humans; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic	2005
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry. Analytical and bioanalytical chemistry, 2005, Volume: 382, Issue:6 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride	2005
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2005
Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. Journal of affective disorders, 2006, Volume: 90, Issue:2-3 Topics: Antidepressive Agents, Second-Generation; Biological Availability; Catechol O-Methyltransferase; Citalopram; Depressive Disorder, Major; Dopamine; Ethnicity; Female; Fluvoxamine; Follow-Up Studies; Frontal Lobe; Genetic Carrier Screening; Genotype; Humans; Male; Methionine; Paroxetine; Personality Inventory; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Valine	2006
Possible antipsychotic effect of fluvoxamine. CNS spectrums, 2005, Volume: 10, Issue:10 Topics: Antipsychotic Agents; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Injections, Intramuscular; Middle Aged; Psychotic Disorders; Risperidone	2005
From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2006, Volume: 16, Issue:6 Topics: Analgesics; Animals; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Pain Measurement; Selective Serotonin Reuptake Inhibitors	2006
Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice. The Chinese journal of physiology, 2005, Dec-31, Volume: 48, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Citalopram; Cocaine; Conditioning, Operant; Female; Fluvoxamine; Male; Maternal Behavior; Mice; Mice, Inbred C57BL; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Stress, Physiological; Trazodone	2005
Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway. Journal of chromatography. A, 2006, May-19, Volume: 1115, Issue:1-2 Topics: Calibration; Chemical Fractionation; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Fluvoxamine; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sewage; Water Pollutants, Chemical	2006
Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases. Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:3 Topics: Child; Citalopram; Female; Fluvoxamine; Humans; Male; Mental Disorders; Nocturnal Enuresis; Selective Serotonin Reuptake Inhibitors; Sertraline	2007
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:10 Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2007
Kinetic and thermodynamic assessment of binding of serotonin transporter inhibitors. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 327, Issue:3 Topics: Antidepressive Agents; Citalopram; Entropy; Fluvoxamine; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Protein Binding; Radioligand Assay; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Static Electricity; Temperature; Thermodynamics	2008
Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats. Canadian journal of physiology and pharmacology, 2008, Volume: 86, Issue:11 Topics: Animals; Antifungal Agents; Antimalarials; Citalopram; Drug Interactions; Fluvoxamine; Ketoconazole; Male; Quinidine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereoisomerism	2008
Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief. Molecular pain, 2009, Apr-23, Volume: 5 Topics: Action Potentials; Animals; Antidepressive Agents; Cell Line, Tumor; Citalopram; Disease Models, Animal; Fluvoxamine; Humans; Injections, Spinal; Male; Pain; Pain Measurement; Paroxetine; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2X4; Serotonin Antagonists; Spinal Cord	2009
Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat. PloS one, 2010, Feb-16, Volume: 5, Issue:2 Topics: Action Potentials; Aniline Compounds; Animals; Antidepressive Agents; Benzofurans; CA3 Region, Hippocampal; Citalopram; Cyclic AMP Response Element-Binding Protein; Drug Synergism; Fluvoxamine; Male; Motor Activity; Neurons; Phosphorylation; Piperazines; Piperidines; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists	2010
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics, 2010, Volume: 125, Issue:5 Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Suicide Prevention; Suicide, Attempted	2010
Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Archives of general psychiatry, 2010, Volume: 67, Issue:5 Topics: Adult; Aged; Antidepressive Agents; British Columbia; Cause of Death; Citalopram; Cohort Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted	2010
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants. Journal of affective disorders, 2011, Volume: 130, Issue:1-2 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride	2011
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2011, Nov-08, Volume: 183, Issue:16 Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine	2011
Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients? International clinical psychopharmacology, 2012, Volume: 27, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Citalopram; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Israel; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Paroxetine; Patient Selection; Personality Assessment; Predictive Value of Tests; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult	2012
The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis. Paediatric drugs, 2013, Volume: 15, Issue:4 Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Canada; Child; Child, Preschool; Citalopram; Databases, Factual; Fluoxetine; Fluvoxamine; Humans; Infant; Mental Disorders; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Sertraline	2013
Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications. Journal of molecular neuroscience : MN, 2014, Volume: 52, Issue:4 Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Citalopram; Clomipramine; Cyclohexanols; Desipramine; Drug Interactions; Fluvoxamine; Male; Methadone; Mice; Mice, Inbred ICR; Morpholines; Nociception; Pain Threshold; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2014
Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients. Therapeutic drug monitoring, 2015, Volume: 37, Issue:4 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Child; Citalopram; Databases, Factual; Drug Monitoring; Drug Utilization; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult	2015
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of affective disorders, 2015, Jul-15, Volume: 180 Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay. Toxicology in vitro : an international journal published in association with BIBRA, 2015, Volume: 29, Issue:7 Topics: Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Citalopram; Estradiol; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Progesterone; Selective Serotonin Reuptake Inhibitors; Sertraline; Testosterone	2015
Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells. Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:9 Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Survival; Citalopram; Cyclopropanes; Duloxetine Hydrochloride; Fluvoxamine; Hep G2 Cells; Humans; Liver Neoplasms; Milnacipran; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline	2015
Management of Newer Antidepressant Medications in U.S. Commercial Health Plans. The journal of mental health policy and economics, 2015, Volume: 18, Issue:4 Topics: Antidepressive Agents; Citalopram; Cost Control; Cost Sharing; Desvenlafaxine Succinate; Drug Costs; Drug Utilization; Duloxetine Hydrochloride; Fluvoxamine; For-Profit Insurance Plans; Health Care Surveys; Health Services Accessibility; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Preferred Provider Organizations; Private Sector; Selegiline; United States; Venlafaxine Hydrochloride	2015
The Effects of Fluvoxamine on the Steady-State Plasma Concentrations of Escitalopram and Desmethylescitalopram in Depressed Japanese Patients. Therapeutic drug monitoring, 2016, Volume: 38, Issue:4 Topics: Asian People; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Depression; Female; Fluvoxamine; Genotype; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors	2016
Effect of antidepressants on spatial memory deficit induced by dizocilpine. Psychiatry research, 2016, Oct-30, Volume: 244 Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride	2016
Application of tandem dispersive liquid-liquid microextraction for the determination of doxepin, citalopram, and fluvoxamine in complicated samples. Journal of separation science, 2016, Volume: 39, Issue:24 Topics: Citalopram; Doxepin; Fluvoxamine; Liquid Phase Microextraction; Solvents	2016
Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications. Clinical toxicology (Philadelphia, Pa.), 2017, Volume: 55, Issue:5 Topics: Child; Child, Preschool; Citalopram; Coma; Dose-Response Relationship, Drug; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Hospitalization; Humans; Infant; Male; Paroxetine; Poison Control Centers; Retrospective Studies; Seizures; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Vilazodone Hydrochloride	2017
Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition. PloS one, 2017, Volume: 12, Issue:7 Topics: Adult; Antidepressive Agents; Citalopram; Databases, Factual; Depressive Disorder; Drug Monitoring; Female; Fluvoxamine; Humans; Norway; Paroxetine; Pregnancy; Pregnancy Trimester, Third; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2017
Risk of hair loss with different antidepressants: a comparative retrospective cohort study. International clinical psychopharmacology, 2018, Volume: 33, Issue:1 Topics: Adolescent; Adult; Alopecia; Antidepressive Agents; Citalopram; Cohort Studies; Female; Fluvoxamine; Humans; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Risk Factors; Venlafaxine Hydrochloride; Young Adult	2018
A comparative study of QT prolongation with serotonin reuptake inhibitors. Psychopharmacology, 2017, Volume: 234, Issue:20 Topics: Adult; Aged; Arrhythmias, Cardiac; Citalopram; Databases, Factual; Female; Fluvoxamine; Humans; Long QT Syndrome; Male; Middle Aged; Paroxetine; Pharmacovigilance; Selective Serotonin Reuptake Inhibitors; Sertraline	2017
Second-generation anti-depressants and risk of new-onset seizures in the elderly. Clinical toxicology (Philadelphia, Pa.), 2018, Volume: 56, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Odds Ratio; Ontario; Population; Seizures	2018
Role of serotonin and noradrenaline in the acute itch processing in mice. European journal of pharmacology, 2019, May-05, Volume: 850 Topics: Animals; Citalopram; Drug Interactions; Fluvoxamine; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Pruritus; Serotonin	2019
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis. Journal of the American Society of Nephrology : JASN, 2019, Volume: 30, Issue:4 Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, Cardiac; Depression; Electrocardiography; Female; Fluoxetine; Fluvoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peroxidase; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States	2019
Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study. Chinese medical journal, 2020, Mar-20, Issue:6 Topics: Antidepressive Agents; Anxiety; Citalopram; Depressive Disorder, Major; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Least-Squares Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2020
The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study. Drug safety, 2022, Volume: 45, Issue:1 Topics: Aged; Antidepressive Agents; Australia; Case-Control Studies; Central Nervous System; Citalopram; Delirium; Fluvoxamine; Humans; Mirtazapine; Nitrazepam; Risk Factors; Sertraline; Venlafaxine Hydrochloride	2022
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants. JAMA network open, 2021, 11-01, Volume: 4, Issue:11 Topics: Adult; Aged; Antidepressive Agents; Citalopram; COVID-19; Cytokines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Prescription Drugs; Retrospective Studies; Risk; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; United States	2021
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022, 10-19, Volume: 37, Issue:11 Topics: Case-Control Studies; Citalopram; Cohort Studies; Death, Sudden, Cardiac; Dialysis Solutions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Potassium; Renal Dialysis; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	2022
Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. Journal of affective disorders, 2022, 12-01, Volume: 318 Topics: Adolescent; Antipsychotic Agents; Citalopram; Diabetes Mellitus, Type 2; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline	2022